cambridge's bluebird bio licenses delivery tech to novartis, gsk.

40 under 40 - bbj class of 2018..

.: "targeted cgrp small molecule antagonists for acute migraine therapy.".

... https://drbryanpwalsh.com/Rosenbluth-brother-of-Ogborn-from-Balgownie?Shearsgra=206

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.